Related Experiment Video
Updated: Nov 8, 2025

06:16
Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
Published on: March 16, 2022
3.3K
Gene Therapy in the Anterior Eye Segment.
Cynthia Amador1, Ruchi Shah1, Sean Ghiam2
1Eye Program, Board of Governors Regenerative Medicine Institute and Department of Biomedical Sciences, Cedars- Sinai Medical Center, Los Angeles, CA, USA.
Current Gene Therapy
|April 27, 2021
Summary
Gene therapy shows promise for anterior eye diseases, utilizing advanced delivery systems and gene editing. This review covers applications for conditions like corneal dystrophies and glaucoma, with ongoing research in human studies.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- Gene therapy offers novel treatment strategies for anterior segment eye diseases.
- The ocular surface presents unique challenges and opportunities for gene therapy delivery.
Purpose of the Study:
- To comprehensively review gene therapy advances in the anterior eye segment.
- To analyze gene therapy applications for various ocular surface diseases and their outcomes.
Main Methods:
- Review of viral and non-viral gene delivery systems.
- Discussion of gene editing (CRISPR-Cas9) and epigenetic therapeutics (antisense, siRNA).
- Analysis of preclinical (in vitro, animal models) and clinical human studies.
Main Results:
- Gene therapy has been tested for corneal fibrosis, wound healing, graft survival, neovascularization, genetic dystrophies, herpetic keratitis, glaucoma, and dry eye.
- Promising outcomes observed in various disease models, with increasing human study data.
- CRISPR-Cas9 and siRNA therapeutics show significant potential.
Conclusions:
- Gene therapy is a rapidly expanding and promising field for treating diverse anterior segment eye diseases.
- Further research and clinical trials are essential to translate preclinical findings into effective human treatments.
- Advanced gene delivery and editing techniques are key to future ocular therapies.
Related Concept Videos
Gene Therapy
26.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
26.4K
Angle Closure Glaucoma: Treatment
920
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
920
Open Angle Glaucoma: Treatment
790
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
790

